
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PDIR CRISPR/Cas9 KO Plasmid (h) | sc-405741 | 20 µg | $397.00 |
PDIA5 encodes the human protein disulfide isomerase-related protein PDIR, an endoplasmic reticulum–resident oxidoreductase that supports oxidative protein folding and disulfide bond isomerization. As a member of the protein disulfide isomerase family, PDIR contributes to ER proteostasis by facilitating maturation of secreted and membrane proteins and coordinating with chaperone networks engaged during the unfolded protein response. PDIA5 activity intersects with ER quality control, redox homeostasis, and ER-associated degradation (ERAD), processes frequently remodeled in cancer, metabolic stress, and neurodegenerative settings. Altered PDI-family function is commonly linked to heightened ER stress signaling and changes in secretory pathway capacity, making PDIA5 a useful node for mechanistic studies of redox-dependent folding.
PDIR CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PDIA5 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PDIA5 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PDIA5 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PDIR protein expression.
This CRISPR knockout system enables efficient generation of PDIA5-deficient cell models for investigation of PDIR signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.